PEGS Europe
PEGS Europe 2025 will bring together scientists, executives, and technology experts to explore topics spanning biologics development, multispecific antibodies, immunotherapy, machine learning in protein engineering, and analytical characterization. As a premier biologics technology meeting in Europe, PEGS offers in-depth technical content, training seminars, poster sessions, and networking and exhibition opportunities for professionals advancing the next generation of therapeutic biologics.
Date: November 11-13, 2025
Location: Lisbon, Portugal
JOIN US!
Accelerate your biologics program with Catalent. At PEGS Europe, discover how our integrated drug substance and drug product services — from cell line development and upstream/downstream processing to aseptic filling of vials, prefilled syringes, and cartridges — help bring therapies to patients faster. Whether you’re advancing a novel biologic or scaling for commercial supply, Catalent’s global expertise and end-to-end solutions streamline development and manufacturing, reduce risk, and enable speed to clinic and market.
Comnplete the form to schedule a meeting with our experts!
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
